← Leaderboards
David Joseph Maloney
Veralox Therapeutics, Inc
$469,133
Attributed
$619,133
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $319.1K · FY2018–20$500K$375K$250K$125K$0
'18
'19
'20
Funding mix
By agency
NIH$619,133 · 2
By mechanism
R43$319,133 · 1
R41$300,000 · 1
Top collaborators
- Raghavendra G Mirmira1 shared
Others in their field
Other Emerging Leaders on “Lox Gene”
- James Dale Berry · Brigham And Women'S Hospital$9,673,541
- Ozgur Sahin · Medical University Of South Carolina$4,595,535
- Diana Jurk · Mayo Clinic Rochester$3,087,661
- Harry Karmouty-Quintana · University Of Texas Hlth Sci Ctr Houston$2,146,983
- Marcin Wysoczynski · University Of Louisville$1,925,000
- Lance Allen Johnson · University Of Kentucky$1,914,100
Research focus
Lox GenePositioning AttributeDrug KineticsLeadNovel TherapeuticsPharmaceutical PreparationsClinical CandidateDoseGrantIn VivoMouse ModelNovel Therapeutic InterventionAnimal ModelOralBiological AvailabilityAutoantibodiesClinically RelevantClinical TrialsEnzymesFirst-In-HumanHourInhibitor/AntagonistArachidonate 12-LipoxygenasePre-Clinical